OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry.
Riccardo M InciardiMuthiah VaduganathanCarlo M LombardiCristina GussagoPiergiuseppe AgostoniPietro AmeriNadia AspromonteLeonardo CalòMatteo CameliErberto CarluccioStefano CarugoManlio CiprianiRaffaele De CaterinaGaetano M De FerrariMichele EmdinAlessandra FornaroMarco GuazziMassimo IacovielloMassimo ImazioMaria Teresa La RovereSergio LeonardiMarta MaccalliniDaniele MasaroneLuigi MoschiniAlberto PalazzuoliGiuseppe PattiRoberto F E PedrettiPasquale Perrone FilardiMassimo F PiepoliLuciano PotenaAndrea SalzanoAngela SciacquaMichele SenniGianfranco SinagraClaudia SpecchiaStefano TaddeiDario VizzaGianluigi SavareseGiuseppe RosanoMaurizio VolterraniMarco Metranull nullPublished in: European journal of heart failure (2024)
The OPTIPHARM-HF registry will provide important implications for improving patient care and adoption of recommended medical therapy into clinical practice among HF patients.